Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Franceschini

Showing results (151-160 of 231) with videos related to

Pageof 24
Sort By:
Clinical and Experimental Rheumatology|July 27, 2022
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosusImmacolata Prevete, Annamaria Iuliano, Alberto Cauli, et al.
Clinical and Experimental Rheumatology|February 26, 2021
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infectionAlberto Batticciotto, Daniela Marotto, Valeria Giorgi, et al.
European Journal of Pain (London, England)|September 26, 2024
Geographical disparities in fibromyalgia severity: An Italian studyMarco Di Carlo, Sonia Farah, Fabiola Atzeni, et al.
Journal of Autoimmunity|September 25, 2020
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective studyPiercarlo Sarzi-Puttini, Daniela Marotto, Roberto Caporali, et al.
Lupus Science & Medicine|June 13, 2025
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohortEmiliano Marasco, Christina Düsing, Stefanie Keymel, et al.
Frontiers in Medicine|June 10, 2022
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient JourneySalvatore D'Angelo, Antonella Afeltra, Fabiola Atzeni, et al.
Annals of the Rheumatic Diseases|July 19, 2022
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational studyAlessandra Bettiol, Maria Letizia Urban, Federica Bello, et al.
Frontiers in Immunology|November 12, 2020
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid SyndromeMaria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Annals of the Rheumatic Diseases|August 1, 2020
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndromeMirko Scarsi, Silvia Piantoni, Enrico Colombo, et al.
Rheumatology (Oxford, England)|February 25, 2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective studyAlessandra Bortoluzzi, Antonis Fanouriakis, Ettore Silvagni, et al.
Pageof 24

Showing results (151-160 of 231) with videos related to

Sort By:
Pageof 24
Clinical and Experimental Rheumatology|July 27, 2022
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosusImmacolata Prevete, Annamaria Iuliano, Alberto Cauli, et al.
Clinical and Experimental Rheumatology|February 26, 2021
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infectionAlberto Batticciotto, Daniela Marotto, Valeria Giorgi, et al.
European Journal of Pain (London, England)|September 26, 2024
Geographical disparities in fibromyalgia severity: An Italian studyMarco Di Carlo, Sonia Farah, Fabiola Atzeni, et al.
Journal of Autoimmunity|September 25, 2020
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective studyPiercarlo Sarzi-Puttini, Daniela Marotto, Roberto Caporali, et al.
Lupus Science & Medicine|June 13, 2025
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohortEmiliano Marasco, Christina Düsing, Stefanie Keymel, et al.
Frontiers in Medicine|June 10, 2022
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient JourneySalvatore D'Angelo, Antonella Afeltra, Fabiola Atzeni, et al.
Annals of the Rheumatic Diseases|July 19, 2022
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational studyAlessandra Bettiol, Maria Letizia Urban, Federica Bello, et al.
Frontiers in Immunology|November 12, 2020
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid SyndromeMaria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Annals of the Rheumatic Diseases|August 1, 2020
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndromeMirko Scarsi, Silvia Piantoni, Enrico Colombo, et al.
Rheumatology (Oxford, England)|February 25, 2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective studyAlessandra Bortoluzzi, Antonis Fanouriakis, Ettore Silvagni, et al.
Pageof 24